Form 424B7 - Prospectus [Rule 424(b)(7)]:
SEC Accession No. 0001144204-19-003213
Filing Date
2019-01-29
Accepted
2019-01-28 18:31:28
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B7 tv511816_424b7.htm 424B7 47346
2 GRAPHIC image_001.jpg GRAPHIC 4174
  Complete submission text file 0001144204-19-003213.txt   54505
Mailing Address 5 WEST FORSYTH STREET SUITE 200 JACKSONVILLE FL 32202
Business Address 5 WEST FORSYTH STREET SUITE 200 JACKSONVILLE FL 32202 (904) 516-5436
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B7 | Act: 33 | File No.: 333-228059 | Film No.: 19546737
SIC: 2834 Pharmaceutical Preparations